Feb 14 (Reuters) - Merus Labs International Inc MSL.TO -
* Gross basis revenue of $30.9 million in fiscal q1 2017
* Adjusted ebitda of $10.8 million in fiscal q1 2017
* Reports fiscal q1 2017 results
* Continues to expect sintrom related product cost savings during 2017 of about half of full annualized potential of $8 million
* Continues to expect sintrom related product cost savings during fiscal 2017
* Says reiterates that fiscal 2017 adjusted ebitda is expected to be in range of $44 to $48 million
* Says fiscal q4 2017 adjusted ebitda is expected to be approximately 25% higher than q1 of fiscal 2017 Source text for Eikon: ID:nCNWcVqhSa Further company coverage: MSL.TO